These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9772323)

  • 1. Chemoprophylaxis compliance in travelers with malaria.
    Behrens RH; Taylor RB; Pryce DI; Low AS
    J Travel Med; 1998 Jun; 5(2):92-4. PubMed ID: 9772323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of malaria prevention measures by North American and European travelers to East Africa.
    Lobel HO; Baker MA; Gras FA; Stennies GM; Meerburg P; Hiemstra E; Parise M; Odero M; Waiyaki P
    J Travel Med; 2001; 8(4):167-72. PubMed ID: 11703900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K; Petersen E
    J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
    Carme B; Peguet C; Nevez G
    Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
    Reyburn H; Behrens RH; Warhurst D; Bradley D
    Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on prevention of malaria for travelers.
    Lobel HO; Kozarsky PE
    JAMA; 1997 Dec; 278(21):1767-71. PubMed ID: 9388154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
    Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D
    Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
    Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
    Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa.
    Wetsteyn JC; de Geus A
    BMJ; 1993 Oct; 307(6911):1041-3. PubMed ID: 8123120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three malaria chemoprophylactic regimens in residents in east, central and southern Africa. A prospective, randomized multicentre trial in The Netherlands.
    Wetsteyn JC; de Geus A
    Trop Geogr Med; 1995; 47(3):103-6. PubMed ID: 7482998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria prevention in travelers.
    Juckett G
    Am Fam Physician; 1999 May; 59(9):2523-30, 2535-6. PubMed ID: 10323359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.
    Lobel HO; Roberts JM; Somaini B; Steffen R
    J Infect Dis; 1987 Jun; 155(6):1205-9. PubMed ID: 3553347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimosquito precautions and medical chemoprophylaxis in French children with malaria.
    Minodier P; Kone-Paut I; Nassur A; Launay F; Jouve JL; Hassid S; Retornaz K; Garnier JM
    J Travel Med; 2003; 10(6):318-23. PubMed ID: 14642197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
    Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.